Sequencing analysis of the leukemic blasts at both diagnosis and relapse indicated disease pathogenesis was initiated by a TET2 nonsense base substitution mutation in exon 3 with a focal 1.1 Mb deletion in the remaining TET2 allele, followed by the acquisition of an NPM1 mutation, giving rise to leukemia. This evidence concerns the gene TET2 and leukemia.